title: Functional expression of the Ile693Thr Na+ channel mutation associated with paramyotonia congenita in a human cell line.
abstract: 1. The Ile693Thr mutation of the skeletal muscle Na+ channel alpha-subunit is associated with an unusual phenotype of paramyotonia congenita characterized by cold-induced muscle weakness but no stiffness. This mutation occurs in the S4-S5 linker of domain II, a region that has not been previously implicated in paramyotonia congenita. 2. The Ile693Thr mutation was introduced into the human skeletal muscle Na+ gene for functional expression in human embryonic kidney (HEK) cells. The currents expressed were recorded with the whole-cell voltage-clamp technique. 3. In comparison with wild-type currents, Ile693Thr mutant currents showed a clear shift of about -9 mV in the voltage dependence of activation. 4. In contrast to other mutations of the Na+ channel known to cause paramyotonia congenita, the Ile693Thr mutation did not induce any significant change in the kinetics, nor in the voltage dependence, of fast inactivation. 5. In conclusion, this study provides further evidence of the involvement of the S4-S5 linker in the voltage dependence of Na+ channel activation. The negative shift in the voltage dependence found in this mutation must be associated to other defects, plausibly an impairment of the slow inactivation, to account for the long periods of muscle weakness experienced by the patients.
authors.affiliation: INSERM CJF9608, Hopital de la Salpetriere, 47 boulevard de l'Hopital, 75651 Paris cedex 13, France.
authors.forename: E
authors.initials: E
authors.lastname: Plassart-Schiess
authors.forename: L
authors.initials: L
authors.lastname: Lhuillier
authors.forename: A L
authors.initials: AL
authors.lastname: George
authors.forename: B
authors.initials: B
authors.lastname: Fontaine
authors.forename: N
authors.initials: N
authors.lastname: Tabti
mesh_terms: D002460:Cell Line; D017931:DNA Primers; D006801:Humans; D007532:Isoleucine; D007668:Kidney; D008564:Membrane Potentials / Q000187:drug effects; D018482:Muscle, Skeletal / Q000378:metabolism*; D016297:Mutagenesis, Site-Directed; D009224:Myotonia Congenita / Q000235:genetics*; D018408:Patch-Clamp Techniques; D017354:Point Mutation; D011188:Potassium / Q000494:pharmacology; D011994:Recombinant Proteins / Q000096:biosynthesis; D015222:Sodium Channels / Q000096:biosynthesis* / Q000235:genetics* / Q000502:physiology; D013696:Temperature; D013912:Threonine; D014162:Transfection
chemical_list: D017931:DNA Primers; D011994:Recombinant Proteins; D015222:Sodium Channels; D007532:Isoleucine; D013912:Threonine; D011188:Potassium